Parkinson's Disease and Experiences Throughout the COVID-19 Pandemic

March 30, 2021 updated by: MacKenzie Forbes, Towson University

Does Locus of Control Affect Satisfaction and Quality of Life During COVID - 19?

The purpose of this research study is to examine the relationship between personal characteristics and satisfaction with care in those diagnosed with Parkinson's disease during the COVID-19 pandemic. Participants will take 4 different surveys regarding their satisfaction with care throughout the duration of the COVID-19 pandemic. The surveys in total should not take more than 30 minutes to complete

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

150

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The study population is people, 18 years or older, who are diagnosed with Parkinson's disease.

Description

Inclusion Criteria:

  • 18 years or older
  • Diagnosed with Parkinson's Disease
  • Must be able to complete the surveys without any help

Exclusion Criteria:

  • Under the age of 18
  • Not diagnosed with Parkinson's Disease
  • Unable to complete the surveys without help

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measure of the relationship between Locus of Control and Quality of Life
Time Frame: 1 year
Participants will take the Multidimensional Health Locus of Control (MHLC) Scale. This will determine if the participant has more of an internal or external locus of control. Participants will also take the Quality of Life Scale- U.S Parkinson's Disease Questionnaire (PDQ-39) to determine the quality of life they have been experiencing throughout the COVID-19 pandemic. Based on the results of both surveys, the researchers will be able to determine if external locus of control or internal locus of control leads to a better quality of life in PD patients throughout the COVID-19 pandemic.
1 year
Measure of secondary control and satisfaction with care
Time Frame: 1 year
Participants will take the Multidimensional Health Locus Control (MHLC) scale. This will determine what type of control is most present in the participant's life. Additionally, participant's will take the Short Form Patient Satisfaction Questionnaire (PSQ-18). This will determine how satisfied participants are with their healthcare providers throughout the COVID-19 pandemic. Based off of the responses to the surveys, the researcher will be able to determine whether a higher or lower secondary control yields a higher satisfaction.
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Towson University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2021

Primary Completion (Anticipated)

April 1, 2021

Study Completion (Anticipated)

May 1, 2021

Study Registration Dates

First Submitted

January 14, 2021

First Submitted That Met QC Criteria

January 19, 2021

First Posted (Actual)

January 22, 2021

Study Record Updates

Last Update Posted (Actual)

April 1, 2021

Last Update Submitted That Met QC Criteria

March 30, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 1352

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quality of Life

Clinical Trials on No Intervention

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Brazil

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe